Recent studies suggest a link between GLP-1 medications like Ozempic and vision loss. Learn about the risks and what you need to know if you're using these popular diabetes drugs.
A new regulator confirmation links Ozempic to a rare eye condition, NAION, affecting diabetes patients. This revelation raises concerns about potential blindness risks associated with semaglutide. Discover the implications for users.
